Literature DB >> 20709768

Vitiligo: concise evidence based guidelines on diagnosis and management.

David J Gawkrodger1, Anthony D Ormerod, Lindsay Shaw, Inma Mauri-Sole, Maxine E Whitton, M Jane Watts, Alex V Anstey, Jane Ingham, Katharine Young.   

Abstract

Vitiligo is a common disease that causes a great degree of psychological distress. In its classical forms it is easily recognised and diagnosed. This review provides an evidence based outline of the management of vitiligo, particularly with the non-specialist in mind. Treatments for vitiligo are generally unsatisfactory. The initial approach to a patient who is thought to have vitiligo is to make a definite diagnosis, offer psychological support, and suggest supportive treatments such as the use of camouflage cosmetics and sunscreens, or in some cases after discussion the option of no treatment. Active therapies open to the non-specialist, after an explanation of potential side effects, include the topical use of potent or highly potent steroids or calcineurin inhibitors for a defined period of time (usually 2 months), following which an assessment is made to establish whether or not there has been a response. Patients whose condition is difficult to diagnose, unresponsive to straightforward treatments, or is causing psychological distress, are usually referred to a dermatologist. Specialist dermatology units have at their disposal phototherapy, either narrow band ultraviolet B or in some cases photochemotherapy, which is the most effective treatment presently available and can be considered for symmetrical types of vitiligo. Depigmenting treatments and possibly surgical approaches may be appropriate for vitiligo in selected cases. There is no evidence that presently available systemic treatments are helpful and safe in vitiligo. There is a need for further research into the causes of vitiligo, and into discovering better treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709768     DOI: 10.1136/pgmj.2009.093278

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

Review 1.  [The 308 nm Excimer laser : Treatment of vitiligo and hypopigmentation].

Authors:  K Fritz; C Salavastru
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 2.  Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review.

Authors:  Alauldin Khalef Alhowaish; Nathalie Dietrich; Meltem Onder; Klaus Fritz
Journal:  Lasers Med Sci       Date:  2012-08-15       Impact factor: 3.161

3.  Identifying Patients at Higher Risk of Depression Among Patients with Vitiligo at Outpatient Setting.

Authors:  Mana Abdullah Alharbi
Journal:  Mater Sociomed       Date:  2020-06

4.  Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Authors:  Jonathan M Eby; Hee-Kap Kang; Jared Klarquist; Shilpak Chatterjee; Jeffrey A Mosenson; Michael I Nishimura; Elizabeth Garrett-Mayer; B Jack Longley; Victor H Engelhard; Shikhar Mehrotra; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-21       Impact factor: 4.693

5.  Chronic diseases among vitiligo patients. A case control study.

Authors:  Abdullah O Al Houssien; Rana O Al Houssien; Waleed Al Ajroush; Hassan S Al Kahtani
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

6.  The Current Status of Antioxidants in the Treatment of Vitiligo in China.

Authors:  Ying Zhou; Manal Khan; Ling Jiang; Chuhan Fu; Yumeng Dong; Liping Luo; Haoran Guo; Lijuan Gao; Xinxin Lei; Li Zhang; Xing Yu; Li Lei; Jinhua Huang; Jing Chen; Qinghai Zeng
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

7.  Multivariate Analysis of Factors Associated with the Koebner Phenomenon in Vitiligo: An Observational Study of 381 Patients.

Authors:  Huma Khurrum; Khalid M AlGhamdi; Khalid M Bedaiwi; Naif Meshael AlBalahi
Journal:  Ann Dermatol       Date:  2017-05-11       Impact factor: 1.444

8.  RIPK1 regulates the survival of human melanocytes upon endoplasmic reticulum stress.

Authors:  Xuecheng Sun; Tao Wang; Bo Huang; Gaobo Ruan; Aie Xu
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.